Advertisement

Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing

      Objectives

      The purpose of this study was to determine the prevalence and spectrum of nonsynonymous polymorphisms (amino acid variants) in the cardiac sodium channel among healthy subjects.

      Background

      Pathogenic mutations in the cardiac sodium channel gene, SCN5A, cause approximately 15 to 20% of Brugada syndrome (BrS1), 5 to 10% of long QT syndrome (LQT3), and 2 to 5% of sudden infant death syndrome.

      Methods

      Using single-stranded conformation polymorphism, denaturing high-performance liquid chromatography, and/or direct DNA sequencing, mutational analysis of the protein-encoding exons of SCN5A was performed on 829 unrelated, anonymous healthy subjects: 319 black, 295 white, 112 Asian, and 103 Hispanic.

      Results

      In addition to the four known common polymorphisms (R34C, H558R, S1103Y, and R1193Q), four relatively ethnic-specific polymorphisms were identified: R481W, S524Y, P1090L, and V1951L. Overall, 39 distinct missense variants (28 novel) were elucidated. Nineteen variants (49%) were found only in the black cohort. Only seven variants (18%) localized to transmembrane-spanning domains. Four variants (F1293S, R1512W, and V1951L cited previously as BrS1-causing mutations and S1787N previously published as a possible LQT3-causing mutation) were identified in this healthy cohort.

      Conclusions

      This study provides the first comprehensive determination of the prevalence and spectrum of cardiac sodium channel variants in healthy subjects from four distinct ethnic groups. This compendium of SCN5A variants is critical for proper interpretation of SCN5A genetic testing and provides an essential hit list of targets for future functional studies to determine whether or not any of these variants mediate genetic susceptibility for arrhythmias in the setting of either drugs or disease.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Huikuri H.V.
        • Castellanos A.
        • Myerburg R.J.
        Sudden death due to cardiac arrhythmias.
        N Engl J Med. 2001; 345: 1473-1482
        • Zipes D.P.
        • Wellens H.J.
        Sudden cardiac death.
        Circulation. 1998; 98: 2334-2351
        • Ackerman M.J.
        Cardiac channelopathies.
        Nat Med. 2004; 10: 463-464
        • Roden D.M.
        • Spooner P.M.
        Inherited long QT syndromes.
        J Cardiovasc Electrophysiol. 1999; 10: 1664-1683
        • Chen Q.
        • Kirsch G.E.
        • Zhang D.
        • Brugada R.
        • Brugada J.
        • Brugada P.
        • Potenza D.
        • Moya A.
        • Borggrefe M.
        • Breithardt G.
        • Ortiz-Lopez R.
        • Wang Z.
        • Antzelevitch C.
        • O’Brien R.E.
        • Schulze-Bahr E.
        • Keating M.T.
        • Towbin J.A.
        • Wang Q.
        Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.
        Nature. 1998; 392: 293-296
        • Priori S.G.
        • Napolitano C.
        • Gasparini M.
        • Pappone C.
        • Della B.P.
        • Giordano U.
        • Bloise R.
        • Giustetto C.
        • De Nardis R.
        • Grillo M.
        • Ronchetti E.
        • Faggiano G.
        • Nastoli J.
        Natural history of Brugada syndrome.
        Circulation. 2002; 105: 1342-1347
        • Wang Q.
        • Shen J.
        • Splawski I.
        • Atkinson D.
        • Li Z.
        • Robinson J.L.
        • Moss A.J.
        • Towbin J.A.
        • Keating M.T.
        SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.
        Cell. 1995; 80: 805-811
        • Splawski I.
        • Shen J.
        • Timothy K.W.
        • Lehmann M.H.
        • Priori S.
        • Robinson J.L.
        • Moss A.J.
        • Schwartz P.J.
        • Towbin J.A.
        • Vincent G.M.
        • Keating M.T.
        Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
        Circulation. 2000; 102: 1178-1185
        • Schwartz P.J.
        • Priori S.G.
        • Dumaine R.
        • Napolitano C.
        • Antzelevitch C.
        • Stramba-Badiale M.
        • Richard T.A.
        • Berti M.R.
        • Bloise R.
        A molecular link between the sudden infant death syndrome and the long-QT syndrome.
        N Engl J Med. 2000; 343: 262-267
        • Ackerman M.J.
        • Siu B.L.
        • Sturner W.Q.
        • Tester D.J.
        • Valdivia C.R.
        • Makielski J.C.
        • Towbin J.A.
        Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.
        JAMA. 2001; 286: 2264-2269
        • Ackerman M.J.
        • Tester D.J.
        • Jones G.
        • Will M.K.
        • Burrow C.R.
        • Curran M.
        Ethnic differences in cardiac potassium channel variants.
        Mayo Clin Proc. 2003; 78: 1479-1487
        • Makielski J.C.
        • Ye B.
        • Valdivia C.R.
        • Pagel M.D.
        • Pu J.L.
        • Tester D.J.
        • Ackerman M.J.
        A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.
        Circ Res. 2003; 93: 821-828
        • Ye B.
        • Valdivia C.R.
        • Ackerman M.J.
        • Makielski J.C.
        A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation.
        Physiol Genom. 2003; 12: 187-193
        • Splawski I.
        • Timothy K.W.
        • Tateyama M.
        • Clancy C.E.
        • Malhotra A.
        • Beggs A.H.
        • Cappuccio F.P.
        • Sagnella G.A.
        • Kass R.S.
        • Keating M.T.
        Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.
        Science. 2002; 297: 1333-1336
        • Roden D.M.
        • George Jr, A.L.
        The genetic basis of variability in drug responses.
        Nat Rev Drug Discov. 2002; 1: 37-44
        • Roden D.M.
        Pharmacogenetics and drug-induced arrhythmias.
        Cardiovasc Res. 2001; 50: 224-231
        • Spooner P.M.
        • Albert C.
        • Benjamin E.J.
        • Boineau R.
        • Elston R.C.
        • George Jr, A.L.
        • Jouven X.
        • Kuller L.H.
        • MacCluer J.W.
        • Marban E.
        • Muller J.E.
        • Schwartz P.J.
        • Siscovick D.S.
        • Tracy R.P.
        • Zareba W.
        • Zipes D.P.
        Sudden cardiac death, genes, and arrhythmogenesis.
        Circulation. 2001; 103: 2361-2364
        • Splawski I.
        • Shen J.
        • Timothy K.
        • Vincent G.M.
        • Lehmann M.H.
        • Keating M.T.
        Genomic structure of three long QT syndrome genes.
        Genomics. 1998; 51: 86-97
        • Antonarakis S.E.
        • Nomenclature Working Group
        Recommendations for a nomenclature system for human gene mutations.
        Human Mutat. 1998; 11: 1-3
      1. http://pc4.fsm.it:81/cardmoc/. Inherited Arrhythmias Database 2004.

        • Rook M.B.
        • Alshinawi C.B.
        • Groenewegen W.A.
        • Van Gelder I.C.
        • Van Ginneken A.C.
        • Jongsma H.J.
        • Mannens M.M.
        • Wilde A.A.
        Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
        Cardiovasc Res. 1999; 44: 507-517
        • Vatta M.
        • Dumaine R.
        • Varghese G.
        • Richard T.A.
        • Shimizu W.
        • Aihara N.
        • Nademanee K.
        • Brugada R.
        • Brugada J.
        • Veerakul G.
        • Li H.
        • Bowles N.E.
        • Brugada P.
        • Antzelevitch C.
        • Towbin J.A.
        Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome.
        Hum Mol Genet. 2002; 11: 337-345
        • Wang Q.
        • Chen S.
        • Chen Q.
        • Wan X.
        • Shen J.
        • Hoeltge G.A.
        • Timur A.A.
        • Keating M.T.
        • Kirsch G.E.
        The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel.
        J Med Genet. 2004; 41: e66
        • Viswanathan P.C.
        • Benson D.W.
        • Balser J.R.
        A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.
        J Clin Invest. 2003; 111: 341-346
        • Takahata T.
        • Yasui-Furukori N.
        • Sasaki S.
        • Igarashi T.
        • Okumura K.
        • Munakata A.
        • Tateishi T.
        Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects.
        Life Sci. 2003; 72: 2391-2399
        • Westenskow P.
        • Splawski I.
        • Timothy K.W.
        • Keating M.T.
        • Sanguinetti M.C.
        Compound mutations.
        Circulation. 2004; 109: 1834-1841
        • Keating M.T.
        • Sanguinetti M.C.
        Molecular and cellular mechanisms of cardiac arrhythmias.
        Cell. 2001; 104: 569-580
        • Hardy J.
        • Singleton A.
        • Gwinn-Hardy K.
        Ethnic differences and disease phenotypes.
        Science. 2003; 300: 739-740
        • Chen S.
        • Chung M.K.
        • Martin D.
        • Rozich R.
        • Tchou P.J.
        • Wang Q.
        SNP S1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family.
        J Med Genet. 2002; 39: 913-915